FrancophonIA/ELRC3.0 huggingface dataset:
English: Ceftriaxon may adversely affect the efficacy of hormonal contraceptives Consequently, it is advisable to use supplementary non-hormonal contraceptive measures.
Slovenian: Ceftriakson lahko neugodno vpliva na učinkovitost hormonskih kontracepcijskih sredstev.
English: Very rare side effects (affects less than 1 out of 10,000 people) reduced or damaged blood cells (increased chance of bleeding, bruising or infection) a type of anaemia that can be severe and is caused by red blood cells breaking up.
Slovenian: Zelo redki stranski učinki (prizadenejo manj kot enega človeka izmed 10.000 ljudi) • zmanjšanje števila ali pa poškodbe krvnih celic (povečana možnost krvavitve, pojava modric ali okužbe)
English: Following an the intravenous infusion of 1 g of ceftriaxone for 30 minutes, serum levels immediately after cessation of the infusion process were at 123.2 µg/ml, and at 94.81, 57.8, 20.2 and 4.6 µg/ml, respectively, 1.5, 4, 12 and 24 hours after the onset of infusion.
Slovenian: Po intravenskem infundiranju 1 g ceftriaksona v 30 minutah so koncentracije v serumu neposredno po prenehanju postopka infundiranja znašale 123,2 µg/ml, 1,5 ure po začetku infundiranja 94,81 µg/ml, po 4 urah 57,8 µg/ml, po 12 urah 20,2 µg/ml in po 24 urah 4,6 µg/ml.
English: Ceftriaxone is a cephalosporin for parenteral administration.
Slovenian: Ceftriakson je cefalosporin za parenteralno dajanje.
English: Miscibility
Slovenian: Nelinearnost
English: Depending on the mode of surgery and the expected spectrum of pathogens ceftriaxone should be combined with an appropriate antimicrobial agent with additional anaerobic coverage.
Slovenian: Odvisno od vrste kirurškega posega in pričakovanega spektra patogenih mikroorganizmov, je treba ceftriakson dajati skupaj z ustreznim protimikrobnim sredstvom, ki dodatno deluje na druge anaerobe.
English: Symptomatic therapeutic measures are indicated.
Slovenian: Specifičnega antidota ni. Indicirani so simptomatski medicinski ukrepi.
English: Simultaneous use of ceftriaxone and bacteriostatic antibiotics is, therefore, not recommended.. Ceftriaxone / probenecid:
Slovenian: Sočasna uporaba ceftriaksona in bakteriostatičnih antibiotikov zato ni priporočljiva.
English: What Ceftriaxone Tyrol Pharma 1g looks like and contents of the pack Ceftriaxone Tyrol Pharma 1g: powder for solution for infusion or injection Ceftriaxone Tyrol Pharma 1 g is a white to yellowish crystalline powder.
Slovenian: Kako Ceftriaxone Tyrol Pharma 1 g izgleda in vsebina pakiranja Ceftriaxone Tyrol Pharma 1 g: prašek za raztopino za infundiranje ali injiciranje Ceftriaxone Tyrol Pharma 1 g je bel do rumenkast kristalen prašek.
English: PHARMACEUTICAL FORM AND CONTENTS Powder for solution for infusion
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA Prašek za raztopino za infundiranje
English: Any unused infusion solution should be disposed of.
Slovenian: Vse neporabljene ostanke raztopin za infundiranje je treba zavreči.
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion should be dissolved in 10 ml of water for injections (resulting volume 10.8 ml, concentration 93 mg/ml).
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 1 g prašek za raztopino za injiciranje ali infundiranje je treba raztopiti v 10 ml vode za injekcije (končni volumen 10,8 ml, koncentracija 93 mg/ml).
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION [To be completed nationally]
Slovenian: DATUM PRIDOBITVE / PODALJŠANJA DOVOLJENJA ZA PROMET [Je treba izpolniti za vsako državo posebej]
English: It is advisable to use supplementary non-hormonal contraceptive measures other active substances like Probenecid.
Slovenian: Priporočljivo je uporabljati dodatne, nehormonske ukrepe za preprečevanje nosečnosti.
English: Intramuscular injection
Slovenian: Intramuskularna injekcija
English: The pharmacokinetics of ceftriaxone are non-linear with respect to the dose.
Slovenian: Farmakokinetika ceftriaksona je, glede na odmerek, nelinearna.
English: Streptococcus pneumoniae*
Slovenian: Streptococcus pyogenes* Streptococcus pneumoniae*
English: Ceftriaxone Tyrol Pharma 2g, powder for solution for infusion, is supplied in packs of 1, 5 and 10 infusion bottles as well as in hospital packs.
Slovenian: Ceftriaxone Tyrol Pharma 2 g, prašek za raztopino za infundiranje je na razpolago v pakiranjih s po 1, 5 ali 10 infuzijskimi stekleničkami, kot tudi v obliki bolnišničnih pakiranj.
English: For intramuscular and intravenous use.
Slovenian: Za intramuskularno in intravensko uporabo.
English: Depending on the mode of surgery and the expected pathogens ceftriaxone should be combined with an appropriate antimicrobial agent with additional coverage of complicating pathogens.
Slovenian: Odvisno od vrste kirurškega posega in pričakovanega spektra patogenih mikroorganizmov, je treba ceftriakson dajati skupaj z ustreznim protimikrobnim sredstvom, ki dodatno deluje na patogene mikroorganizme, ki povzročajo zaplete.
English: The WHO recommends even 80 mg/kg/day respectively 2 x 50mg/kg/every 12 hours (max single dose 4g) in meningitis for young infants aged between 7 days and 2 months.
Slovenian: SZO za meningitis pri novorojencih, starih od 7 dni do 2 mesecev, priporoča celo 80 mg/kg/dan, tj. 2 x 50mg/kg/vsakih 12 ur (največji enkratni odmerek 4 g).
English: Ceftriaxone Tyrol Pharma 2g must never be mixed with any of the following solutions: - solutions containing calcium such as Hartmann's and Ringer's solutions.
Slovenian: Ceftriaxone Tyrol Pharma 2 g se nikoli ne sme mešati s katero izmed naslednjih raztopin: - raztopine, ki vsebujejo kalcij, kot sta Hartmannova raztopina in Ringerjeva raztopina.
English: Ceftriaxone crosses the placenta and is excreted in human milk at low concentrations.
Slovenian: Ceftriakson prehaja preko placente ter se v majhnih koncentracijah izloča v materino mleko.
English: Adults and adolescents aged over 12 years with a body weight ≥ 50 kg:
Slovenian: Odrasli in otroci, starejši od 12 let, s telesno maso ≥ 50 kg:
English: Hypersensitivity reactions may occur in all degrees of severity up to anaphylactic shock (see section
Slovenian: Preobčutljivostne reakcije se lahko pojavijo v vseh stopnjah izraženosti, vse do anafilaktičnega šoka (glejte poglavje 4.8).
English: Ceftriaxone concentrates in the urine.
Slovenian: Ceftriakson se koncentrira v seču.
English: For people with kidney problems, the dose does not need to be reduced, if hepatic function is normal.
Slovenian: • Pri bolnikih, ki imajo težave z ledvicami, odmerka ni treba zmanjševati, če je delovanje jeter normalno.
English: Intramuscular and intravenous use
Slovenian: Intramuskularna in intravenska uporaba
English: Ceftriaxone Tyrol Pharma 1g must never be mixed with any of the following solutions: - solutions containing calcium such as Hartmann's and Ringer's solutions.
Slovenian: Ceftriaxone Tyrol Pharma 1 g se nikoli ne sme mešati s katero izmed naslednjih raztopin: - raztopine, ki vsebujejo kalcij, kot sta Hartmannova raztopina in Ringerjeva raztopina.
English: For intramuscular administration Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection dissolved in lidocaine hydrochloride solution is injected deep into the gluteus maximus muscle.
Slovenian: Pri intramuskularnem dajanju se Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 1 g prašek za raztopino za injiciranje, raztopljen v raztopini lidokainijevega klorida, injicira globoko v mišico gluteus maximus.
English: Important information about some of the ingredients of Ceftriaxone Tyrol Pharma 1g Ceftriaxone Tyrol Pharma 1g contains 83mg (equivalent to approx. 3.6mmol) sodium per dose.
Slovenian: Pomembni podatki o nekaterih sestavinah zdravila Ceftriaxone Tyrol Pharma 1 g Ceftriaxone Tyrol Pharma 1 g vsebuje 83 mg (kar ustreza 3.6 m molom) natrija v enem odmerku.
English: Important information about some of the ingredients of Ceftriaxone Tyrol Pharma 2g Ceftriaxone Tyrol Pharma 2g contains 166mg, (equivalent to approx. 7.2mmol) sodium per dose.
Slovenian: Pomembni podatki o nekaterih sestavinah zdravila Ceftriaxone Tyrol Pharma 2 g Ceftriaxone Tyrol Pharma 2 g vsebuje 166 mg (kar ustreza 7,2 m molom) natrija v enem odmerku.
English: Read the package leaflet before use.
Slovenian: Pred uporabo preberite navodilo za uporabo zdravila.
English: Ceftriaxone is excreted in low concentrations in breast milk.
Slovenian: Ceftriakson se v majhnih koncentracijah izloča v materino mleko.
English: PHARMACEUTICAL FORM AND CONTENTS Powder for solution for injection or infusion
Slovenian: FARMACEVTSKA OBLIKA IN VSEBINA Prašek za raztopino za injiciranje ali infundiranje
English: In particular, ceftriaxone is not compatible with calcium-containing solutions such as Hartmann's solution and Ringer's solution.
Slovenian: Še posebno pomembno je poudariti, da ceftriakson ni kompatibilen z raztopinami, ki vsebujejo kalcij, kot sta Hartmannova raztopina in Ringerjeva raztopina).
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion may be administered by intravenous bolus injection, by intravenous infusion or by intramuscular injection after reconstitution of the solution according to the directions given below (see section 6.6).
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 1 g prašek za raztopino za injiciranje ali infundiranje se lahko daje z intravensko bolus injekcijo, z intravensko infuzijo ali z intramuskularno injekcijo po tem, ko je bila raztopina pripravljena skladno s spodaj navedenimi navodili (glejte poglavje 6.6).
English: For other routes of administration other strengths of ceftriaxone are available.
Slovenian: Za druge načine dajanja so na razpolago druge jakosti ceftriaksona.
English: 1 Some strains produce inducible or stably derepressed chromosomally-encoded cephalosporinases and ESBLs (extended spectrum beta-lactamases) and thus are clinically resistant to cephalosporins.
Slovenian: 1 Nekateri sevi tvorijo kromosomsko kodirane cefalosporine in ESBL (beta laktamaze z razširjenim spektrom), ki odpravo represije sprožijo ali pa je represija trajno odpravljena, in so na ta način klinično odporni na cefalosporine.
English: Pain and induration of tissue at the site of injection occur after intramuscular injection.
Slovenian: Po intramuskularnem injiciranju se na mestu injiciranja pojavita bolečina in okorelost tkiva.
English: Ceftriaxone Tyrol Pharma 1g, powder for solution for injection or infusion is supplied in packs of 1, 5 and 10 vials as well as in hospital packs.
Slovenian: Ceftriaxone Tyrol Pharma 1 g, prašek za raztopino za injiciranje ali infundiranje je na razpolago v pakiranjih s po 1, 5 ali 10 vialami, kot tudi v obliki bolnišničnih pakiranj.
English: Intravenous injection
Slovenian: Intravenska injekcija
English: When reconstituted for intramuscular or intravenous injection, the white to yellowish crystalline powder gives a pale yellow to amber solution.
Slovenian: Ko sta intramuskularna ali intravenska injekcija pripravljeni, bel do rumenkast kristaliničen prašek da bledo rumeno do rumenkasto rjavo raztopino.
English: Dosages greater than 1 g should be divided and injected on more than one site Not more than 1 g of ceftriaxone should be injected on either side of the body (see section 4.2).
Slovenian: Na eno in drugo stran telesa se ne sme injicirati več kot 1 g ceftriaksona (glejte poglavje 4.2).
English: See also section 2 “Take special care with Ceftriaxone Tyrol Pharma 1g”.
Slovenian: Glejte tudi poglavje 2 "Pri uporabi Ceftriaxone Tyrol Pharma 1 g morate biti posebno pozorni"
English: Do not use Ceftriaxone Tyrol Pharma 2 g if you notice the following: The solution is not clear.
Slovenian: Ceftriaxone Tyrol Pharma 2 g ne uporabljajte če opazite naslednje: Raztopina ni bistra.
English: In severe infections the daily dose of 80 mg per kg bodyweight must not be exceeded, except in meningitis (refer to: Special dosage recommendations).
Slovenian: Pri hudih okužbah ne sme biti presežen dnevni odmerek 80 mg na kg telesne teže, razen pri meningitisu (glejte posebna priporočila za odmerjanje).
English: blood poisoning (sepsis)
Slovenian: • zastrupitve krvi (sepse)
English: Do not use Ceftriaxone Tyrol Pharma 1 g if you notice the following: The solution is not clear.
Slovenian: Ceftriaxone Tyrol Pharma 1 g ne uporabljajte če opazite naslednje: Raztopina ni bistra.
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 2 g powder for solution for infusion should be administered by intravenous infusion after reconstitution of the solution according to the directions given below (see section 6.6).
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 2 g prašek za raztopino za infundiranje je treba dajati z intravensko infuzijo po tem, ko je bila raztopina pripravljena skladno s spodaj navedenimi navodili (glejte poglavje 6.6).
English: Staphylococcus aureus*(MSSA) Streptococcus agalactiae Streptococcus bovis Streptococcus pyogenes*
Slovenian: Staphylococcus aureus*(MSSA) Streptococcus agalactiae Streptococcus bovis
English: Headache, dizziness, vertigo.
Slovenian: Glavobol, vrtoglavica, omotica.
English: What Ceftriaxone Tyrol Pharma 2g is and what it is used for Before you use Ceftriaxone Tyrol Pharma 2g How to use Ceftriaxone Tyrol Pharma 2g Possible side effects
Slovenian: Kaj je Ceftriaxone Tyrol Pharma 2 g in za kaj se uporablja Kaj morate vedeti pred uporabo Ceftriaxone Tyrol Pharma 2 g Kako je treba uporabljati Ceftriaxone Tyrol Pharma 2 g Možni neželeni učinki
English: When reconstituted for intravenous infusion, the white to yellowish crystalline powder gives a pale yellow to amber solution.
Slovenian: Ko je intravenska infuzija pripravljena, bel do rumenkast kristaliničen prašek da bledo rumeno do rumenkasto rjavo raztopino.
English: You are allergic (hypersensitive) to ceftriaxone or to any of the other ingredients of this medicine You are allergic (hypersensitive) to any other cephalosporin type of antibiotic.
Slovenian: • Ste alergični (preobčutljivi) na katerikoli drug antibiotik cefalosporinske vrste
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion is reconstituted with 10 ml of one of the compatible intravenous fluids in its vial.
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 1 g prašek za raztopino za injiciranje ali infundiranje se v njegovi viali pomeša z 10 ml ene izmed kompatibilnih intravenskih tekočin.
English: Normal dosage
Slovenian: Običajno odmerjanje
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion should be dissolved in 3.5 ml of 1 % w/v lidocaine hydrochloride injection solution.
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 1 g prašek za raztopino za injiciranje ali infundiranje je treba raztopiti v 3,5 ml 1% ut/v raztopine lidokainijevega klorida za injiciranje.
English: Ceftriaxone crosses the placenta.
Slovenian: Ceftriakson prehaja preko placente.
English: This medicine has been prescribed for you.
Slovenian: - To zdravilo je bilo predpisano vam, zato ga ne smete dati drugim.
English: Aminoglycosides:
Slovenian: Aminoglikozidi:
English: Elderly above 75 years: The plasma elimination half-life of ceftriaxone is about 2 - 3 fold increased compared to young adults.
Slovenian: V primerjavi z mladimi odraslimi je razpolovni čas izločanja ceftriaksona iz plazme podaljšan za približno 2 do 3-krat.
English: What Ceftriaxone Tyrol Pharma 1g is and what it is used for Before you use Ceftriaxone Tyrol Pharma 1g How to use Ceftriaxone Tyrol Pharma 1g Possible side effects
Slovenian: Kaj je Ceftriaxone Tyrol Pharma 1 g in za kaj se uporablja Kaj morate vedeti pred uporabo Ceftriaxone Tyrol Pharma 1 g Kako je treba uporabljati Ceftriaxone Tyrol Pharma 1 g Možni neželeni učinki
English: Patients with an impaired renal function, as well as an impaired liver function, may have an increased ceftriaxone plasma elimination half-life.
Slovenian: Pri bolnikih z zmanjšanim delovanjem ledvic, ki imajo obenem tudi zmanjšano delovanje jeter, pa je razpolovni čas izločanja ceftriaksona iz plazme lahko podaljšan.
English: Calcium treatment because of the risk of precipitation of ceftriaxone-calcium salt in term newborn.
Slovenian: Zdravljenje s kalcijem zaradi tveganja za nastanek oborin ceftriakson-kalcijeve soli pri pravočasno rojenih novorojencih.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 g vial contains 1 g ceftriaxone (as hydrated disodium).
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka 1 g viala vsebuje 1 g ceftriaksona (v obliki hidratirane dinatrijeve soli).
English: Ceftriaxone Tyrol Pharma 2g is injected into a vein (intravenous administration).
Slovenian: Ceftriaxone Tyrol Pharma 2 g se injicira v veno (intravensko dajanje).
English: GROUNDS FOR AMENDMENT OF THE SUMMARIES OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET
Slovenian: PODLAGA ZA DOPOLNITEV POVZETKOV GLAVNIH ZNAČILNOSTI ZDRAVILA, OZNAČEVANJA IN NAVODIL ZA UPORABO
English: Ceftriaxone is normally given by a doctor or nurse It is given as an injection.
Slovenian: Ceftriakson običajno daje zdravnik ali medicinska sestra
English: Adults, older people and children 12 years and over who weigh more than 50kg 1 to 2g once a day
Slovenian: Odrasli, starejši ljudje in otroci, stari 12 let in več, ki tehtajo več kot 50 kg
English: The dose does not need to be altered in patients with a liver disease provided that the renal function is normal (see section 4.8).
Slovenian: Pri bolnikih z zmanjšanim delovanjem jeter odmerka ceftriaksona ni potrebno spreminjati, če je delovanje ledvic normalno (glejte poglavje 4.8).
English: You have ever been told that your kidneys and/or liver do not work very well You have ever had gall bladder or kidney stones, or you are nourished intravenously If you have ever had inflammation of your bowel, called colitis, or any other severe disease affecting your gut
Slovenian: • Ste kadarkoli v preteklosti imeli vnetje črevesja, imenovano kolitis, ali katerokoli drugo hudo obolenje, ki je prizadelo vaša prebavila
English: For other routes of administration other strengths of Ceftriaxone Tyrol Pharma are available.
Slovenian: Za druge načine dajanja so na razpolago drugačne jakosti zdravila Ceftriaxone Tyrol Pharma.
English: 20 - 50 mg per kg bodyweight intravenously once daily (24-hour intervals).
Slovenian: 20 do 50 mg na kilogram telesne mase intravensko enkrat dnevno (24-urni presledki).
English: 20-80 mg per kg bodyweight intravenously once daily (24-hour intervals).
Slovenian: 20-80 mg na kg telesne teže intravensko enkrat na dan (v 24-urnih presledkih).
English: Therapy of intoxication
Slovenian: Zdravljenje zastrupitve
English: MARKETING AUTHORISATION NUMBER(S) [To be completed nationally]
Slovenian: ŠTEVILKA DOVOLJENJA ZA PROMET [Je treba izpolniti za vsako državo posebej]
English: Children 15 days-12 years of age with a body weight of < 50 kg:
Slovenian: Otroci, stari od 15 dni do 12 let, s telesno težo < 50 kg:
English: PHARMACOLOGICAL PROPERTIES
Slovenian: Farmakodinamične lastnosti
English: the CHMP has recommended by majority the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Ceftriaxone Tyrol Pharma and associated names (see Annex I).
Slovenian: ¾ Povzetek glavnih značilnosti zdravila, označevanje in Navodila za uporabo, ki jih je predlagal vlagatelj, so bili ocenjeni na temelju predložene dokumentacije in znanstvene razprave v odboru je CHMP z večino glasov priporočil odobritev dovoljenja za promet z zdravilom Ceftriaxone Tyrol Pharma in z njim povezanih imen (glejte Dodatek I), za katerega so Povzetek glavnih značilnosti zdravila, označevanje in Navodila za uporabo navedeni v Dodatku III.
English: reduced or damaged blood cells (increased chance of bleeding, bruising or infection) a type of anaemia that can be severe and is caused by red blood cells breaking up.
Slovenian: • zmanjšanje števila ali pa poškodbe krvnih celic (povečana možnost krvavitve, pojava modric ali okužbe)
English: MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Slovenian: IMETNIK DOVOLJENJA ZA PROMET [Glejte Prilogo I - Je treba izpolniti za vsako državo posebej]
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each 2 g infusion bottle contains 2 g ceftriaxone (as hydrated disodium).
Slovenian: KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka 2 g infuzijska steklenička vsebuje 2 g ceftriaksona (v obliki hidratirane dinatrijeve soli).
English: Ceftriaxone Tyrol Pharma 1g should not be used in newborn with jaundice (hyperbilirubinaemia) or preterm newborn because the use of ceftriaxone, the active substance of Ceftriaxone Tyrol Pharma 1g can leed to complications with possible brain damage in these patients.
Slovenian: • Ceftriaxone Tyrol Pharma 1 g se ne sme uporabljati pri novorojenčkih z zlatenico (hiperbilirubinemija) ali nedonošenčkih, ker lahko uporaba ceftriaksona, učinkovine v Ceftriaxone Tyrol Pharma 1 g, vodi k zapletom z možno okvaro možganov pri teh bolnikih.
English: Very rare side effects (affects less than 1 out of 10,000 people)
Slovenian: Zelo redki stranski učinki (prizadenejo manj kot enega človeka izmed 10.000 ljudi)
English: For example, thrush may occur Kidney problems: changed in kidney function and reduced urine production
Slovenian: • Ledvične težave: spremembe v delovanju ledvic in zmanjšano nastajanje seča
English: Intravenous infusion
Slovenian: Intravenska infuzija
English: The adverse reactions (e.g. gastrointestinal disturbances and nephrotoxicity) associated with high parenteral doses of cephalosporins have been shown to be reversible in animals during repeat dosing.
Slovenian: Po ponavljajočem se dajanju živalim so ugotovili, da so neželeni stranski učinki (na primer prebavne motnje in nefrotoksičnost), povezani z velikimi odmerki cefalosporinov, reverzibilni.
English: Following side effects are very rare (affect less than 1 out of 10,000 people).
Slovenian: Naslednji stranski učinki so zelo redki (prizadenejo manj kot enega človeka izmed 10.000 ljudi).
English: Following side effects are rare (affect less than 1 in 1000 people).
Slovenian: Naslednji stranski učinki so redki (prizadenejo manj kot enega človeka izmed 1000 ljudi).
English: Ceftriaxone Tyrol Pharma 2g should not be used in newborn with jaundice (hyperbilirubinaemia) or preterm newborn because the use of ceftriaxone, the active substance of Ceftriaxone Tyrol Pharma 2g can leed to complications with possible brain damage in these patients.
Slovenian: • Ceftriaxone Tyrol Pharma 2 g se ne sme uporabljati pri novorojenčkih z zlatenico (hiperbilirubinemija) ali nedonošenčkih, ker lahko uporaba ceftriaksona, učinkovine v Ceftriaxone Tyrol Pharma 2 g, vodi k zapletom z možno okvaro možganov pri teh bolnikih.
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 1 g powder for solution for injection or infusion [See Annex I - To be completed nationally]
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 1 g prašek za raztopino za injiciranje ali infundiranje [Glejte Prilogo I - Je treba izpolniti za vsako državo posebej]
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Bottle
Slovenian: PODATKI, KI SE NAHAJAJO NA STIČNI OVOJNINI Steklenička
English: Ceftriaxone Tyrol Pharma and associated names (See Annex I) 2 g powder for solution for infusion [See Annex I - To be completed nationally]
Slovenian: Ceftriaxon Tyrol Pharma in druga imena (Glejte Prilogo I) 2 g prašek za raztopino za infundiranje [Glejte Prilogo I - Je treba izpolniti za vsako državo posebej]
English: Ceftriaxone Tyrol Pharma 1g can be administered by the intramuscular route.
Slovenian: Ceftriaxone Tyrol Pharma 1 g se lahko daje intramuskularno.
English: Not more than 1 g of ceftriaxone should be injected on either side of the body.
Slovenian: Na eno in drugo stran telesa se ne sme injicirati več kot 1 g ceftriaksona.